Senate Probe Targets Federal Funding for Minors’ Gender Transition Services and Legal Liability Costs
Why It Matters
A Senate investigation is raising questions about whether billions in federal taxpayer dollars flow to health providers giving gender transition treatments to minors — and whether the federal government is also picking up the legal tab when former patients sue those same providers for harm.
The inquiry, led by Sen. Bill Cassidy (R-La.), chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee, centers on community health centers that receive substantial federal funding and may carry federal liability protections — protections that could put the Justice Department in the position of defending providers whose practices the current administration has sought to restrict.
What Happened
Cassidy sent letters to two Rhode Island health care providers — Thundermist Health Center and Hasbro Children’s Hospital in Providence — asking them to account for reported services involving puberty blockers, cross-sex hormones, surgical referrals, or related treatments provided to patients under 19 years old.
He also sent a separate letter to the Health Resources and Services Administration (HRSA), the federal agency that oversees the Health Center Program, demanding details about what enforcement steps, if any, have been taken against federally funded centers offering such services to minors.
The move expands earlier scrutiny that began in February, when the general counsel of the Department of Health and Human Services (HHS) referred several federally funded community health centers to the HHS Office of Inspector General for investigation. It was not immediately clear whether that investigation has produced public findings.
A Senate hearing is scheduled for the coming week to examine federal funding and liability protections tied to gender transition procedures for children.
By the Numbers
Cassidy’s letter to HRSA highlights the scale of federal support flowing to community health centers. For fiscal year 2026, those centers are set to receive more than $6.3 billion in combined mandatory and discretionary federal funding. The HRSA Health Center Program separately receives $120 million to administer its Federal Tort Claims Act (FTCA) program.
At Thundermist specifically, the letter notes that 66 percent of the center’s fiscal year 2024 grants and contributions revenue came from HHS and associated federal health programs. The center also benefits from enhanced Medicare and Medicaid reimbursement rates and participation in the 340B federal drug pricing program.
Hasbro Children’s Hospital serves as a pediatric facility in Providence and is among the centers now under formal congressional inquiry.
The Liability Question
A central concern in Cassidy’s inquiry involves federal tort liability rules governing certain community health centers. Under existing law, some federally supported providers and their staff are treated as employees of the U.S. Public Health Service for malpractice liability purposes. That means when lawsuits arise, the Justice Department — not the individual provider — often handles the legal defense under the Federal Tort Claims Act.
Cassidy argues that this structure creates a significant accountability gap, particularly as lawsuits from individuals seeking to reverse prior gender transition procedures continue to mount across the country. In his letter, the senator cited multiple cases in which the DOJ has represented community health centers or their providers in transition-related litigation.
“Patients alleging harm from gender transition-related services may be forced to litigate against the full resources of the federal government, rather than the individual providers responsible for their care,” Cassidy wrote, adding that the current framework raises questions about whether federal funds are effectively insulating providers from accountability.
Zoom Out
The Senate probe fits within a broader federal effort to scrutinize and curtail gender transition services for minors. The Justice Department has separately moved to tighten enforcement in other immigration and civil rights contexts, reflecting an administration-wide posture of stricter accountability for entities receiving federal support.
Multiple states have enacted laws restricting or banning gender transition procedures for minors, and a growing wave of civil litigation from detransitioners has pushed the issue into federal court. Congressional oversight of federally funded providers is emerging as an additional layer of that national debate.
Documents from one Rhode Island health center described an intake pathway for patients under 18 seeking hormone treatments, conditioned on parental consent. Another center publicly lists transgender health services and operates an adolescent health program serving LGBTQ youth between ages 13 and 24.
What’s Next
The HELP Committee hearing scheduled for next week is expected to examine both the scope of federal funding for these services and the liability protections that may shield providers from direct legal accountability. Cassidy’s letters to HRSA and the two Rhode Island providers set deadlines for formal responses, though those deadlines were not specified in available materials.
The HHS Inspector General’s earlier referrals remain unresolved publicly, and Cassidy’s letter specifically asks HRSA to detail any enforcement actions taken since those referrals were made in February.